Clinical Trial: A Randomized, Phase 3 Multicenter Study to Confirm the Clinical Efficacy of Linaprazan Glurate Compared to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07037875) titled 'A Randomized, Phase 3 Multicenter Study to Confirm the Clinical Efficacy of Linaprazan Glurate Compared to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)' on June 17.

Brief Summary: The goal of this clinical trial is to find out how well linaprazan glurate can heal erosive esophagitis (EE) caused by gastroesophageal reflux disease (GERD), compared to lansoprazole, a commonly used medication. Researchers will also evaluate whether linaprazan glurate:

* Reduces heartburn symptoms more effectively than lansoprazole

* Is safe and well tolerated, based on physical exams, blood t...